ID18698A - Komposisi farmasi - Google Patents

Komposisi farmasi

Info

Publication number
ID18698A
ID18698A IDP973554A ID973554A ID18698A ID 18698 A ID18698 A ID 18698A ID P973554 A IDP973554 A ID P973554A ID 973554 A ID973554 A ID 973554A ID 18698 A ID18698 A ID 18698A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IDP973554A
Other languages
English (en)
Inventor
Gary Wayne Goodson
Allen Wayne Wood
Katherine Jeannette Ford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID18698A publication Critical patent/ID18698A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IDP973554A 1996-10-31 1997-10-30 Komposisi farmasi ID18698A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ID18698A true ID18698A (id) 1998-04-30

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP973554A ID18698A (id) 1996-10-31 1997-10-30 Komposisi farmasi

Country Status (43)

Country Link
EP (1) EP0941100B1 (id)
JP (1) JP2001502718A (id)
KR (1) KR100551652B1 (id)
AP (1) AP1067A (id)
AR (1) AR009135A1 (id)
AT (1) ATE241364T1 (id)
AU (1) AU736607B2 (id)
BG (1) BG64541B1 (id)
BR (1) BR9712614A (id)
CA (1) CA2270174A1 (id)
CO (1) CO4930269A1 (id)
CY (1) CY2485B1 (id)
CZ (1) CZ296080B6 (id)
DE (1) DE69722433T2 (id)
DK (1) DK0941100T3 (id)
EA (1) EA002437B1 (id)
EE (1) EE03806B1 (id)
ES (1) ES2200204T3 (id)
GB (1) GB9622681D0 (id)
GE (1) GEP20022735B (id)
GT (1) GT199700116A (id)
HR (1) HRP970569B1 (id)
HU (1) HU224969B1 (id)
ID (1) ID18698A (id)
IL (1) IL129422A0 (id)
IS (1) IS5024A (id)
MY (1) MY119513A (id)
NO (1) NO317163B1 (id)
NZ (1) NZ335153A (id)
OA (1) OA11038A (id)
PA (1) PA8441101A1 (id)
PE (1) PE10099A1 (id)
PL (1) PL190349B1 (id)
PT (1) PT941100E (id)
SI (1) SI0941100T1 (id)
SK (1) SK284286B6 (id)
SV (1) SV1997000090A (id)
TR (1) TR199900950T2 (id)
UA (1) UA64725C2 (id)
UY (1) UY24766A1 (id)
WO (1) WO1998018477A2 (id)
YU (1) YU19999A (id)
ZA (1) ZA979726B (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AU2002311622A1 (en) * 2002-04-23 2003-11-10 Lupin Limited Long acting compositions comprising zidovudine and lamivudine
ATE361059T1 (de) * 2002-11-08 2007-05-15 Glaxo Group Ltd Antivirale zusammensetzungen
PT1583542E (pt) 2003-01-14 2008-09-17 Gilead Sciences Inc Composições e métodos para terapia de combinação antiviral
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
CN114010776A (zh) 2010-06-09 2022-02-08 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
CA2866133A1 (en) 2012-03-05 2013-09-12 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
US20140234415A1 (en) * 2013-02-20 2014-08-21 Abbvie Inc. Tablet Dosage Forms
JP2023010676A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
ATE131730T1 (de) * 1991-05-16 1996-01-15 Glaxo Group Ltd Nukleosidanalogen enthaltende antiviren- zubereitungen
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
DE69722433D1 (de) 2003-07-03
UY24766A1 (es) 2000-12-29
PA8441101A1 (es) 2000-05-24
NO992091D0 (no) 1999-04-29
AP1067A (en) 2002-05-01
SV1997000090A (es) 1998-10-07
BG103435A (en) 2000-04-28
HRP970569B1 (en) 2004-10-31
BG64541B1 (bg) 2005-07-29
EE9900175A (et) 1999-12-15
HK1020880A1 (en) 2000-05-26
PL190349B1 (pl) 2005-11-30
GB9622681D0 (en) 1997-01-08
GEP20022735B (en) 2002-07-25
DE69722433T2 (de) 2004-04-08
AU736607B2 (en) 2001-08-02
PE10099A1 (es) 1999-03-02
WO1998018477A3 (en) 1998-06-18
AP9901519A0 (en) 1999-06-30
ES2200204T3 (es) 2004-03-01
PT941100E (pt) 2003-10-31
EA002437B1 (ru) 2002-04-25
SK284286B6 (sk) 2005-01-03
NZ335153A (en) 2001-04-27
ZA979726B (en) 1999-04-29
DK0941100T3 (da) 2003-09-01
IS5024A (is) 1999-04-09
EA199900345A1 (ru) 2000-02-28
CZ155799A3 (cs) 1999-10-13
WO1998018477A2 (en) 1998-05-07
HRP970569A2 (en) 1998-08-31
ATE241364T1 (de) 2003-06-15
JP2001502718A (ja) 2001-02-27
EP0941100B1 (en) 2003-05-28
HUP0000344A3 (en) 2002-04-29
NO992091L (no) 1999-06-29
OA11038A (en) 2002-02-06
IL129422A0 (en) 2000-02-17
CA2270174A1 (en) 1998-05-07
BR9712614A (pt) 1999-10-26
PL333143A1 (en) 1999-11-22
KR100551652B1 (ko) 2006-02-13
SI0941100T1 (en) 2003-12-31
CZ296080B6 (cs) 2006-01-11
YU19999A (sh) 2000-10-30
UA64725C2 (uk) 2004-03-15
KR20000052893A (ko) 2000-08-25
CO4930269A1 (es) 2000-06-27
EE03806B1 (et) 2002-08-15
AU5314298A (en) 1998-05-22
TR199900950T2 (xx) 1999-07-21
HUP0000344A2 (hu) 2001-05-28
AR009135A1 (es) 2000-03-08
SK57599A3 (en) 2000-06-12
MY119513A (en) 2005-06-30
GT199700116A (es) 1999-04-22
CY2485B1 (en) 2005-06-03
NO317163B1 (no) 2004-08-30
EP0941100A2 (en) 1999-09-15
HU224969B1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
ID18352A (id) Komposisi-komposisi farmasi
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
NO20021172D0 (no) Farmasöytisk sammensetning
FI20071025L (fi) Farmaseuttisia koostumuksia
FI991302A7 (fi) Parannetut farmaseuttiset koostumukset
ID17774A (id) Komposisi farmasi antitrombosis
BR9507768A (pt) Composição farmacêutica
ID29294A (id) Komposisi farmasi
LV11727A (lv) Farmaceitiska kompozicija
FI973229A7 (fi) Uusi farmaseuttinen koostumus
PT941100E (pt) Composicoes farmaceuticas
ID25857A (id) Komposisi farmasi
FI973280A0 (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI961364L (fi) Lääkeainekoostumus
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
FI962767A0 (fi) Dataoeverfoeringsfoerfarande
FI954050L (fi) Lääkekoostumuksia
FI962738A7 (fi) Farmaseuttiset koostumukset
ID23531A (id) Komposisi farmasi
NO964309D0 (no) Farmasöytisk sammensetning
SE9604299D0 (sv) Pharmaceutical composition
ID17133A (id) Komposisi farmasi
SE9601854D0 (sv) Farmaceutisk komposition